SCHEMBL14628587

SCHEMBL14628587

COC(=O)NC(CCC(=O)O)C(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.41
▸ TET2 Q6N021 3/20 0.39
▸ KDM4A O75164 2/20 0.39
▸ KDM4C Q9H3R0 2/20 0.39
▸ KDM2A Q9Y2K7 2/20 0.39
▸ TET3 O43151 1/20 0.39
▸ FOLH1 Q04609 10/20 0.38
▸ RIMKLA Q8IXN7 1/20 0.38
▸ NAALAD2 Q9Y3Q0 1/20 0.38
▸ GABRP O00591 2/20 0.38
▸ GABRD O14764 2/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB1 P18505 2/20 0.38
▸ GABRG2 P18507 2/20 0.38
▸ GABRB3 P28472 2/20 0.38
▸ GABRA5 P31644 2/20 0.38
▸ GABRA3 P34903 2/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ GABRB2 P47870 2/20 0.38
▸ GABRA4 P48169 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10965852 0.83 TSHR (0.39) TSHRTET2KDM4AKDM4CKDM2A
SCHEMBL14597980 0.74 FOLH1 (0.64) FOLH1RIMKLANAALAD2
SCHEMBL14497656 0.74 FOLH1 (0.64) FOLH1RIMKLANAALAD2
SCHEMBL25745387 0.74 REN (0.41) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL31450785 0.73 FOLH1 (0.47) FOLH1RIMKLANAALAD2
SCHEMBL21150988 0.73 FOLH1 (0.47) TSHRTET2KDM4AKDM4CKDM2A
SCHEMBL18756332 0.72 GABRP (0.45) TSHRTET2KDM4AKDM4CKDM2A
SCHEMBL28230319 0.72 CTSK (0.45) FOLH1
SCHEMBL27880264 0.72 FOLH1 (0.37) TSHRTET2KDM4AKDM4CKDM2A
SCHEMBL25745409 0.72 FOLH1 (0.44) TET2KDM4AKDM4CKDM2ATET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070009980-A1 Continuous fluorogenic analyte assays with dendritic amplification of signal APPLERA CORPORATION (US) 2007-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070009980-A1 Continuous fluorogenic analyte assays with dendritic amplification of signal CD69, FLT3, IRF3 TSHR 1600/4885TET2 746/4885KDM4A 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback